4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-004200
Chief Scientific Officer sold 13,673 shares at $8.22 ($112,367)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barone Francesca Chief Scientific Officer | 2025-01-08 | Sale | −13,673 | $8.22 | $112,367 | 124,207 | D: show line 1 in the form |
| Open-market sales · 13,673 sh · avg $8.22 · $112,367 | |||||||
Loading xslF345X05/ownership.xml…